Mold Forces Recall of Compounded Drugs in Pennsylvania
Visible mold has been found in bags of an injection drug made at a New Jersey compounding pharmacy. Fifty-millimeter bags of the medication, magnesium sulfate intravenous solution, were distributed to at least 13 hospitals in Pennsylvania, Connecticut, Delaware, and New Jersey.
Magnesium sulfate is commonly used to replace electrolytes in hospitalized patients. Versions packed in plastic syringes were also distributed nationwide to doctors' offices and clinics.
Last week, Connecticut officials identified "visible floating particles" in the solution which led to the confirmation of mold contamination. It is not yet known how many patients received the potentially dangerous drugs, though 88 orders ranging in size from 10 to 500 bags are affected. The product was distributed to hospitals between February 18 and March 13.
The pharmacy, Med Prep Consulting Inc., is temporarily closed and has recalled all lots of all products, according to the U.S. Food and Drug Administration. Officials say the recall may affect thousands of bags, syringes, and vials of premixed solutions. Med Prep produces antibiotics, local and general anesthetics, cardiac, labor and delivery, and pain medications, among other things.
This recall comes six months after contaminated injection steroids led to a deadly fungal meningitis outbreak. Those drugs were also manufactured at a compounding pharmacy.